Bioelectronics Corp (BIEL)

[srinsocal]

Breaking Research on PEMFs Healing Benign Prostate Hyperplasia

Thousands of studies on PEMF therapy and how it works have shown that it can reduce inflammation as it oxygenates the tissues in the body.
The electromagnetic fields have also been shown to increase blood flow, possibly preventing blockages in veins, arteries, and blood vessels.
Additionally, EMF’s have been shown to reduce swelling as the result of reducing inflammation in and around muscles, joints, and tissues.
This lends credence to the studies on BHP in that the electromagnetic fields could reduce the swelling of the prostate.
This age-related impairment of blood flow could potentially be reversed, thus causing the prostate to return to its normal size.

https://www.pemftherapyeducation.com/2017/04/breaking-research-pemfs-healing-benign-prostate-hyperplasia/
***********************************************

Mechanisms and therapeutic effectiveness of pulsed electromagnetic field therapy in oncology

Cancer is one of the most common causes of death worldwide. Available treatments are associated with numerous side effects and only a low percentage of patients achieve complete remission. Therefore, there is a strong need for new therapeutic strategies. In this regard, pulsed electromagnetic field (PEMF) therapy presents several potential advantages including non-invasiveness, safety, lack of toxicity for non-cancerous cells, and the possibility of being combined with other available therapies. Indeed, PEMF stimulation has already been used in the context of various cancer types including skin, breast, prostate, hepatocellular, lung, ovarian, pancreatic, bladder, thyroid, and colon cancer in vitro and in vivo.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5119968/
*********************************************************
Effects of pulsed electromagnetic fields on benign prostate hyperplasia

Benign prostate hyperplasia (BPH) has been treated with various types of electromagnetic radiation methods such as transurethral needle ablation (TUNA), interstitial laser therapy (ILC), holmium laser resection (HoLRP). In the present study, the effects of a noninvasive method based on the exposure of patients with BPH to a pulsative EM Field at radiofrequencies have been investigated. Twenty patients with BPH, aging 68-78 years old (y.o), were enrolled in the study. Patients were randomly divided into two groups: the treatment group (10 patients, 74.0 ± 5.7 y.o) treated with the a-blocker Alfusosin, 10 mg/24 h for at least 4 weeks, and the electromagnetic group (10 patients, 73.7 ± 6.3 y.o) exposed for 2 weeks in a very short wave duration, pulsed electromagnetic field at radiofrequencies generated by an ion magnetic inductor, for 30 min daily, 5 consecutive days per week. Patients of both groups were evaluated before and after drug and EMF treatment by values of total PSA and prostatic PSA fraction, acid phosphate, U/S estimation of prostate volume and urine residue, urodynamic estimation of urine flow rate, and International Prostate Symptom Score (IPSS). There was a statistically significant decrease before and after treatment of IPSS (P < 0.02), U/S prostate volume (P < 0.05), and urine residue (P < 0.05), as well as of mean urine flow rate (P < 0.05) in patients of the electromagnetic group, in contrast to the treatment group who had only improved IPSS (P < 0.05). There was also a significant improvement in clinical symptoms in patients of the electromagnetic group. Follow-up of the patients of this group for one year revealed that results obtained by EMFs treatment are still remaining. Pulsed electromagnetic field at radiofrequencies may benefit patients with benign prostate hyperplasia treated by a non-invasive method.

https://www.researchgate.net/publication/215724021_Effects_of_pulsed_electromagnetic_fields_on_benign_prostate_hyperplasia
*******************************************************